Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/9478
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease
Author: Tam, W.
Schoeman, M.
Zhang, Q.
Dent, J.
Tippett, R.
Utley, D.
Holloway, R.
Citation: Gut, 2003; 52(4):479-485
Publisher: British Med Journal Publ Group
Issue Date: 2003
ISSN: 0017-5749
1468-3288
Statement of
Responsibility: 
W C E Tam, M N Schoeman, Q Zhang, J Dent, R Rigda, D Utley, R H Holloway
Abstract: <h4>Background and aims</h4>Radiofrequency energy (RFe) treatment to the lower oesophageal sphincter (LOS) and gastric cardia is a new luminally delivered therapy proposed as an alternative treatment for gastro-oesophageal reflux disease (GORD). However, it is unclear how RFe achieves its antireflux effect. This study investigated the effects of RFe on mechanisms of spontaneous reflux in patients with GORD.<h4>Methods</h4>Twenty patients with GORD underwent endoscopy, symptom evaluation, and combined postprandial oesophageal manometry and pH monitoring before and six months after RFe, and 24 hour ambulatory pH monitoring before and at six and 12 months after treatment.<h4>Results</h4>RFe reduced the rate of postprandial transient LOS relaxations from 6.8 (5.7-8.1) (median (interquartile range) per hour to 5.2 (4.2-5.8) per hour (p<0.01), and increased mean basal LOS pressure from 5.2 (SEM 0.3) mm Hg to 8.0 (SEM 0.4) mm Hg (p<0.01). The number of reflux events was reduced from 10 (2-15.3)/3 hours to 5 (3.5-8.5)/3 hours (p<0.05) and there was an associated significant reduction in acid exposure time from 5.4% (0.4-14.7) to 3.9% (0.4-6.6) (p<0.05). RFe significantly reduced ambulatory oesophageal acid exposure from 10.6% (7.8-13.0) to 6.8% (3.1-9.1) (p<0.01) at six months and 6.3% (4.7-10.9) (p<0.05) at 12 months. All patients required acid suppressant medication for symptom control before RFe. Six months after treatment, 15 patients (75%) were in symptomatic remission and 13 (65%) at 12 months.<h4>Conclusions</h4>RFe has significant effects on LOS function that are associated with improvement in the antireflux barrier. Uncontrolled clinical data also suggest a beneficial effect in the control of reflux symptoms in these patients.
Keywords: Esophagogastric Junction
Cardia
Humans
Gastroesophageal Reflux
Antacids
Catheter Ablation
Monitoring, Ambulatory
Treatment Outcome
Drug Administration Schedule
Follow-Up Studies
Postprandial Period
Muscle Relaxation
Hydrogen-Ion Concentration
Adult
Aged
Middle Aged
Female
Male
DOI: 10.1136/gut.52.4.479
Published version: http://dx.doi.org/10.1136/gut.52.4.479
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.